Carnegie Investment Counsel - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,284 filers reported holding NOVARTIS A G in Q2 2024. The put-call ratio across all filers is 1.04 and the average weighting 0.2%.

Quarter-by-quarter ownership
Carnegie Investment Counsel ownership history of NOVARTIS A G
ValueSharesWeighting
Q2 2024$1,175,000
+10.1%
11,037
+0.0%
0.04%
+12.1%
Q1 2024$1,067,416
-8.6%
11,035
-4.6%
0.03%
-17.5%
Q4 2023$1,168,224
-1.3%
11,570
-0.4%
0.04%
-11.1%
Q3 2023$1,183,818
-1.8%
11,622
-2.7%
0.04%0.0%
Q2 2023$1,205,573
+9.4%
11,947
-0.2%
0.04%
+2.3%
Q1 2023$1,101,701
-2.7%
11,975
-4.0%
0.04%
-10.2%
Q4 2022$1,131,733
+18.9%
12,475
-0.4%
0.05%
+8.9%
Q3 2022$952,000
-7.1%
12,521
+3.2%
0.04%
-2.2%
Q2 2022$1,025,000
-1.8%
12,130
+2.0%
0.05%
+21.1%
Q1 2022$1,044,000
+0.2%
11,895
-0.2%
0.04%
+11.8%
Q4 2021$1,042,000
+14.6%
11,916
+7.2%
0.03%0.0%
Q3 2021$909,000
-10.4%
11,1160.0%0.03%
-10.5%
Q2 2021$1,014,000
+9.1%
11,116
+2.3%
0.04%
-2.6%
Q1 2021$929,000
-11.9%
10,864
-2.7%
0.04%
-17.0%
Q4 2020$1,054,000
+2.1%
11,164
-5.9%
0.05%
-11.3%
Q3 2020$1,032,000
-0.6%
11,869
-0.2%
0.05%
-11.7%
Q2 2020$1,038,000
+6.0%
11,8890.0%0.06%
-11.8%
Q1 2020$979,000
-13.3%
11,889
-0.3%
0.07%
+4.6%
Q4 2019$1,129,000
+9.0%
11,9240.0%0.06%
-1.5%
Q3 2019$1,036,000
-8.2%
11,924
-3.4%
0.07%
-9.6%
Q2 2019$1,128,000
-6.6%
12,349
-1.7%
0.07%
-12.0%
Q1 2019$1,208,000
+6.9%
12,566
-4.6%
0.08%
-21.0%
Q4 2018$1,130,000
-14.0%
13,166
-12.1%
0.10%
-2.8%
Q3 2018$1,314,000
+23.5%
14,972
+15.6%
0.11%
+33.3%
Q2 2018$1,064,000
+1.2%
12,951
-4.4%
0.08%
-8.0%
Q1 2018$1,051,000
-9.5%
13,549
-0.9%
0.09%
-14.6%
Q4 2017$1,161,000
+22.0%
13,673
+23.4%
0.10%
-7.2%
Q3 2017$952,000
-0.4%
11,083
-1.2%
0.11%
-4.3%
Q2 2017$956,000
+7.2%
11,215
-0.9%
0.12%
+4.5%
Q1 2017$892,000
-2.4%
11,315
-8.8%
0.11%
-9.0%
Q4 2016$914,000
-1.7%
12,402
+0.8%
0.12%
-9.0%
Q3 2016$930,000
-40.1%
12,302
-34.3%
0.13%
-38.8%
Q2 2016$1,552,000
+17.1%
18,717
+2.3%
0.22%
+7.9%
Q1 2016$1,325,000
-4.0%
18,292
+3.1%
0.20%
-15.1%
Q4 2015$1,380,000
-5.0%
17,742
+10.2%
0.24%
-4.4%
Q3 2015$1,453,000
+2.1%
16,103
+11.3%
0.25%
+0.4%
Q2 2015$1,423,000
+18.9%
14,473
+24.8%
0.25%
+20.3%
Q1 2015$1,197,000
+22.9%
11,597
+13.4%
0.21%
+13.1%
Q4 2014$974,000
+4.2%
10,230
+3.0%
0.18%
-1.6%
Q3 2014$935,000
-1.7%
9,930
-5.5%
0.19%
-13.9%
Q2 2014$951,000
+7.8%
10,505
+1.3%
0.22%
-6.9%
Q1 2014$882,000
+5.8%
10,3700.0%0.23%
+3.6%
Q4 2013$834,000
+4.0%
10,370
-0.8%
0.22%
-9.3%
Q3 2013$802,000
+13.8%
10,450
+4.8%
0.25%
+6.5%
Q2 2013$705,0009,9750.23%
Other shareholders
NOVARTIS A G shareholders Q2 2024
NameSharesValueWeighting ↓
Martin Investment Management, LLC 318,637$27,960,0007.08%
MANAGED ASSET PORTFOLIOS, LLC 417,183$36,608,0005.02%
SAL Trading, LLC 233,600$20,498,0004.77%
SCHARF INVESTMENTS, LLC 1,340,680$117,662,0003.49%
SAL Trading, LLC 155,783$13,670,0003.18%
First Fiduciary Investment Counsel, Inc. 169,371$14,862,0002.90%
PRENTISS SMITH & CO INC 55,026$4,829,0002.90%
GARLAND CAPITAL MANAGEMENT INC 47,630$4,180,0002.77%
Cullen Capital Management, LLC 3,295,271$289,160,0002.66%
WILKINS INVESTMENT COUNSEL INC 133,880$11,748,0002.65%
View complete list of NOVARTIS A G shareholders